14/01/2021: THERADIAG signs a contract to supply ORGENTEC with quality control reagents called Alegria® Check

Croissy-Beaubourg, January 14, 2021, 5:45 pm CET – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, today announces that it has signed an partnership contract with ORGENTEC, a German…

Continue Reading 14/01/2021: THERADIAG signs a contract to supply ORGENTEC with quality control reagents called Alegria® Check

11/01/2021: THERADIAG announces CE marking for four new i-Tracker® test kits for biotherapy monitoring

Croissy-Beaubourg, January 11, 2021, 5:45pm CET – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, today announces that it has obtained CE marking for four additional i-Tracker® test kits…

Continue Reading 11/01/2021: THERADIAG announces CE marking for four new i-Tracker® test kits for biotherapy monitoring